Lazar Veronica, Holban Alina-Maria, Curutiu Carmen, Ditu Lia Mara
Department of Botany and Microbiology, Faculty of Biology, University of Bucharest, Bucharest, Romania.
Laboratory of Microbiology, Research Institute of the University of Bucharest, Bucharest, Romania.
Front Nutr. 2022 Jul 8;9:920413. doi: 10.3389/fnut.2022.920413. eCollection 2022.
Microbiota plays a crucial role in human health and disease; therefore, the modulation of this complex and yet widely unexplored ecosystem is a biomedical priority. Numerous antibacterial alternatives have been developed in recent years, imposed by the huge problem of antibioresistance, but also by the people demand for natural therapeutical products without side effects, as dysbiosis, cyto/hepatotoxicity. Current studies are focusing mainly in the development of nanoparticles (NPs) functionalized with herbal and fruit essential oils (EOs) to fight resistant pathogens. This is due to their increased efficiency against susceptible, multidrug resistant and biofilm embedded microorganisms. They are also studied because of their versatile properties, size and possibility to ensure a targeted administration and a controlled release of bioactive substances. Accordingly, an increasing number of studies addressing the effects of functional nanoparticles and plant products on microbial pathogens has been observed. Regardless the beneficial role of EOs and NPs in the treatment of infectious diseases, concerns regarding their potential activity against human microbiota raised constantly in recent years. The main focus of current research is on gut microbiota (GM) due to well documented metabolic and immunological functions of gut microbes. Moreover, GM is constantly exposed to micro- and nano-particles, but also plant products (including EOs). Because of the great diversity of both microbiota and chemical antimicrobial alternatives (i.e., nanomaterials and EOs), here we limit our discussion on the interactions of gut microbiota, inorganic NPs and EOs. Impact of accidental exposure caused by ingestion of day care products, foods, atmospheric particles and drugs containing nanoparticles and/or fruit EOs on gut dysbiosis and associated diseases is also dissected in this paper. Current models developed to investigate mechanisms of dysbiosis after exposure to NPs/EOs and perspectives for identifying factors driving EOs functionalized NPs dysbiosis are reviewed.
微生物群在人类健康和疾病中起着至关重要的作用;因此,调节这个复杂但尚未得到充分探索的生态系统是生物医学的一个优先事项。近年来,由于抗生素耐药性这一巨大问题,同时也由于人们对无副作用的天然治疗产品(如生态失调、细胞/肝毒性)的需求,已经开发出了许多抗菌替代品。目前的研究主要集中在开发用草药和水果精油(EOs)功能化的纳米颗粒(NPs),以对抗耐药病原体。这是因为它们对易感、多重耐药和生物膜嵌入微生物的效率更高。由于它们具有多种特性、尺寸以及能够确保生物活性物质的靶向给药和控释,因此也对它们进行了研究。相应地,越来越多的研究关注功能纳米颗粒和植物产品对微生物病原体的影响。尽管EOs和NPs在治疗传染病方面具有有益作用,但近年来人们对它们对人类微生物群的潜在活性的担忧不断增加。由于肠道微生物的代谢和免疫功能有充分记录,目前的研究主要集中在肠道微生物群(GM)上。此外,GM不断暴露于微米和纳米颗粒,以及植物产品(包括EOs)。由于微生物群和化学抗菌替代品(即纳米材料和EOs)的多样性很大,在这里我们将讨论限制在肠道微生物群、无机NPs和EOs的相互作用上。本文还剖析了因摄入含有纳米颗粒和/或水果EOs的日托产品、食品、大气颗粒和药物而导致的意外暴露对肠道生态失调及相关疾病的影响。综述了目前为研究暴露于NPs/EOs后生态失调的机制而开发的模型,以及识别驱动EOs功能化NPs生态失调的因素的前景。